<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-19490" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Chorea</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Merical</surname>
            <given-names>Brandon</given-names>
          </name>
          <aff>ETSU Quillen College of Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>S&#x000e1;nchez-Manso</surname>
            <given-names>Juan Carlos</given-names>
          </name>
          <aff>Hospital Nuestra Se&#x000f1;ora del Rosario</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Brandon Merical declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Juan Carlos S&#x000e1;nchez-Manso declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>10</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-19490.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>According to the Committee on Classification of the World Federation of Neurology, chorea is defined as "a state of excessive, spontaneous movements, irregularly timed, non-repetitive, randomly distributed and abrupt in character. These movements may vary in severity from restlessness with mild intermittent exaggeration of gesture and expression, fidgeting movements of the hands, unstable dance-like gait to a continuous flow of disabling, violent movements." Chorea, similar to choreography, refers to movements that resemble dancing. Chorea usually is accompanied by athetosis and ballism. Athetosis is a slower form of chorea. The slowed movements have a writhing or twisting motion. Ballism is a very severe form of chorea where there is a violent flinging of the extremities. The movements are involuntary and usually involve the limbs. Ballismus is usually unilateral but, rarely, may be bilateral. This activity examines when this condition should be considered on differential diagnosis and how to properly evaluate it. This activity highlights the role of the interprofessional team in caring for patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the various causes that can lead to a presentation of chorea.</p></list-item><list-item><p>Describe the diagnostic testing and approach in evaluating a patient who presents with chorea.</p></list-item><list-item><p>Outline management strategies for chorea, including both medical and surgical therapies.</p></list-item><list-item><p>Explain the importance of improving coordination among the interprofessional team to enhance care for patients affected by chorea.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=19490&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=19490">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-19490.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>According to the Committee on Classification of the World Federation of Neurology, chorea is defined as "a state of excessive, spontaneous movements, irregularly timed, non-repetitive, randomly distributed and abrupt&#x000a0;in character. These movements may vary in severity from restlessness with mild intermittent exaggeration of gesture and expression, fidgeting movements of the hands, unstable dance-like gait to a continuous flow of disabling, violent movements." Chorea, similar to choreography, refers to movements that resemble dancing.&#x000a0;<xref ref-type="bibr" rid="article-19490.r1">[1]</xref><xref ref-type="bibr" rid="article-19490.r2">[2]</xref><xref ref-type="bibr" rid="article-19490.r3">[3]</xref><xref ref-type="bibr" rid="article-19490.r4">[4]</xref><xref ref-type="bibr" rid="article-19490.r5">[5]</xref></p>
        <p>Chorea usually is accompanied by athetosis and ballism. Athetosis is a slower form of chorea. The slowed movements have a writhing or twisting motion. Ballism is a very severe form of chorea where there is violent flinging of the extremities. The movements are involuntary and usually involve the limbs. Ballismus is usually unilateral but, rarely, may be bilateral.</p>
      </sec>
      <sec id="article-19490.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Chorea classically is described in Huntington disease, but there are other disorders that can lead to chorea. Spinocerebellar ataxia subtypes, Wilson disease, Sydenham chorea, and structural disease of the basal ganglia can also be associated with chorea. Overall, the root of the pathology is in the basal ganglia, often exemplified by neuro-imaging demonstrating atrophy of the caudate nucleus. Huntington disease is a hereditary cause of chorea and is one of the tri-nucleotide repeat disorders. Huntington disease is caused by a CAG repeat on chromosome 4 in the Huntington, or HTT gene.&#x000a0;<xref ref-type="bibr" rid="article-19490.r6">[6]</xref><xref ref-type="bibr" rid="article-19490.r7">[7]</xref><xref ref-type="bibr" rid="article-19490.r8">[8]</xref></p>
        <p>
<bold>Other Causes</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Endocrine and metabolic: hypoglycemia, hyperthyroidism, kernicterus, hypomagnesemia</p>
          </list-item>
          <list-item>
            <p>Infectious: rheumatic fever, syphilis, subacute sclerosing panencephalitis, Lyme disease, toxoplasmosis, HIV, endocarditis</p>
          </list-item>
          <list-item>
            <p>Drugs: levodopa, oral contraceptive, neuroleptics, antihistamines, cocaine, amphetamine, tricyclics</p>
          </list-item>
          <list-item>
            <p>Toxins: CO poisoning, mercury, alcohol intoxication</p>
          </list-item>
          <list-item>
            <p>Neurologic: stroke, migraine</p>
          </list-item>
          <list-item>
            <p>Vascular: polycythemia, Churg Strauss, SLE, Behcet, Multiple sclerosis</p>
          </list-item>
          <list-item>
            <p>Malignant: primary brain tumors and metastatic lesion</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-19490.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>While the incidence of chorea in specific disorders is known, the global incidence of chorea is lacking. The incidence of chorea in some common disorders is&#x000a0;as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Huntington disease</bold> is a neurodegenerative autosomal dominant disorder with a prevalence of about 5-10 cases per 100,000 individuals in the US. The disorder is most common in Caucasians but is now being seen in expats who have settled in South and Central America.</p>
          </list-item>
          <list-item>
            <p><bold>Wilson disease</bold> is a multisystem disorder that is autosomal recessive and has a prevalence of about 30 cases per million people.</p>
          </list-item>
          <list-item>
            <p><bold>Benign hereditary chorea</bold> is a rare disorder with autosomal dominant inheritance with a prevalence of 1 case per half a million people.</p>
          </list-item>
        </list>
        <p>
<bold>Age</bold>
</p>
        <p>Chorea can occur at any age. In young people, the most common causes of chorea are infections, trauma, and inflammatory causes.&#x000a0;</p>
        <p>Huntington chorea usually presents in the fourth to fifth decade of life and is progressive. It is rarely seen before the third decade of life. Individuals who have early onset of the disorder usually inherit the gene from the father, whereas late onset is most likely due to a gene inherited from the mother.</p>
      </sec>
      <sec id="article-19490.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>This is a disease that has its roots in genetics. The mutated huntingtin protein contains numerous glutamate residues due to the CAG repeats. It is thought that these mutated HTT proteins will aggregate instead of folding to form functional proteins. This is associated with cellular dysfunction.&#x000a0; &#x000a0;</p>
        <p>Neurotransmitters involved in chorea, include dopamine, acetylcholine, serotonin, &#x000a0;GABA substance P, and cannabinoids.</p>
      </sec>
      <sec id="article-19490.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The universal feature of patients with chorea is that they exhibit uncontrolled motor impersistence&#x000a0;such that they are not able to maintain a steady posture, position, or movement. For example, when asked to grip an object, they will alternately continue to release and squeeze. Another feature is the constant dropping of objects.</p>
        <p>Chorea can involve both the distal and proximal muscles. While most patients do&#x000a0;have normal muscle tone, a few may have hypotonia</p>
        <p>Most commonly, excessive unintentional movements of parts of the body lead to medical consultation. These choreiform movements are clearly&#x000a0;visible on observation. Other common findings are motor impersistence of the tongue, where the patient displays an inability to keep the tongue protruded&#x000a0;when asked to stick their tongue out. The tongue will dart into and out of the mouth. MRI will display caudate atrophy, exemplified by the widening of the lateral ventricles. Later findings of the disease include cognitive and behavioral symptoms.&#x000a0;</p>
      </sec>
      <sec id="article-19490.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Evaluation of a patient with Huntington disease can include genetic testing, CT/MRI, and a psychiatric evaluation for deficits in cognitive, behavioral, and functional areas. Inquiry about suicidality is important.<xref ref-type="bibr" rid="article-19490.r9">[9]</xref><xref ref-type="bibr" rid="article-19490.r10">[10]</xref><xref ref-type="bibr" rid="article-19490.r11">[11]</xref><xref ref-type="bibr" rid="article-19490.r12">[12]</xref></p>
        <p>PET is often used to assess patients with Huntington chorea and neuroacanthocytosis. Bilateral reduction in metabolism in the putamen and the caudate nucleus is frequently seen. However, the reduction in metabolism may not be seen in patients with benign hereditary chorea.</p>
      </sec>
      <sec id="article-19490.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>There is no cure for this disease; however, symptoms can be managed. Perhaps most important is evaluation and creation of a patient's support system. As the disease progresses, the patient will need specialized caregiving. Nutrition management is important, due to difficulty swallowing. Tetrabenazine has been approved for treatment of chorea.&#x000a0;</p>
        <p>
<bold>Medical Care</bold>
</p>
        <p>The majority of patients are treated with neuroleptics, which block dopamine receptors. Other drugs that are used include GABaergic agents like valproate, clonazepam, and gabapentin. Both minocycline and CoQ10 have shown promise in animals. Chorea that occurs following heart transplant may respond to steroids, and plasmapheresis may shorten the course of chorea in patients with rheumatic fever. For the most part, drugs only reduce the chorea in a few patients, and they also have potent adverse effects.</p>
        <p>
<bold>Surgery</bold>
</p>
        <p>In the past decade, deep brain stimulation (DBS) has been developed and may provide some&#x000a0;benefit to some patients with chorea. Anecdotal reports indicate that in selected patients, the procedure does work and reduces chorea. DBS is done by placing electrodes in the globus pallidus internus. However, DBS is still an experimental surgical procedure. It does not work in all patients with chorea, and the procedure is associated with a number of complications.</p>
        <p>Neural cell transplantation is another experimental procedure which has been used to treat a few patients with Huntington chorea, but the improvement has not been seen in all patients.</p>
      </sec>
      <sec id="article-19490.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Huntington disease</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Lesch-Nyhan disease</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Lyme disease</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Multiple system atrophy</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Neuroacanthocytosis</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Pediatric torticollis surgery</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Ramsay Hunt syndrome</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Striatonigral degeneration</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Tourette syndrome</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Viral encephalitis</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-19490.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis of chorea depends on the cause. The majority of patients with Huntington chorea have a poor prognosis and will die prematurely. The same applies to patients with neuroacanthocytosis. When the involuntary movements are severe, this may result in localized trauma or rhabdomyolysis.</p>
        <p>In patients with neuroacanthocytosis and those who develop tongue dystonia, swallowing may be affected, resulting in loss of body weight, recurrent episodes of aspiration pneumonia, and even death.</p>
      </sec>
      <sec id="article-19490.s11" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Huntington's disease, neuroacanthocytosis, and Wilson disease are genetic disorders hence counseling should be provided to any couple who plans to conceive, especially if one partner has the disorder.</p>
        <list list-type="bullet">
          <list-item>
            <p>Genetic testing should be offered to any family member if they want to know the potential risk of inheriting the disease</p>
          </list-item>
          <list-item>
            <p>Educate all patients on the clinical features of the disease options for treatment and prognosis.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-19490.s12" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The management of chorea is complex because there is no cure. All the currently available treatments are palliative which only manage the symptoms. While the patients are primarily managed by the neurologist, the follow up maybe by the primary care provider and nurse practitioner. The most important is feature is&#x000a0;the creation of the patient's support system. As the disease progresses, the patient will need specialized caregiving. Nutrition management is important, due to difficulty swallowing. Genetic testing should be offered to any family member if they want to know the potential risk of inheriting the disease. Educate all patients on the clinical features of the disease options for treatment and prognosis. The prognosis for most patients is poor and the quality of life is markedly diminished.<xref ref-type="bibr" rid="article-19490.r13">[13]</xref> (Level V)</p>
      </sec>
      <sec id="article-19490.s13">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=19490&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=19490">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/neurology/chorea/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=19490">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/19490/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=19490">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-19490.s14">
        <title>References</title>
        <ref id="article-19490.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mehta</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Goyal</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Kilbane</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lal</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>An Unusual and Intriguing Presentation of Sydenham's Chorea.</article-title>
            <source>Tremor Other Hyperkinet Mov (N Y)</source>
            <year>2018</year>
            <volume>8</volume>
            <fpage>593</fpage>
            <pub-id pub-id-type="pmid">30783549</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19490.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vasudevan</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Laway</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Wani</surname>
                <given-names>AI</given-names>
              </name>
              <name>
                <surname>Wani</surname>
                <given-names>MM</given-names>
              </name>
            </person-group>
            <article-title>Chorea Associated with Nonketotic Hyperglycemia (Diabetic Striatopathy) in an Elderly Male.</article-title>
            <source>Indian J Endocrinol Metab</source>
            <year>2018</year>
            <season>Nov-Dec</season>
            <volume>22</volume>
            <issue>6</issue>
            <fpage>859</fpage>
            <page-range>859-860</page-range>
            <pub-id pub-id-type="pmid">30766836</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19490.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Delhasse</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Debove</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Arnold-Kunz</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ghika</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Chabwine</surname>
                <given-names>JN</given-names>
              </name>
            </person-group>
            <article-title>Erratic movement disorders disclosing Graves' disease and paralleling thyroid function but not autoantibody levels.</article-title>
            <source>J Int Med Res</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>47</volume>
            <issue>3</issue>
            <fpage>1378</fpage>
            <page-range>1378-1386</page-range>
            <pub-id pub-id-type="pmid">30761931</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19490.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Crosiers</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Blaumeiser</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Van Goethem</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Spectrum of Movement Disorders in 18p Deletion Syndrome.</article-title>
            <source>Mov Disord Clin Pract</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>6</volume>
            <issue>1</issue>
            <fpage>70</fpage>
            <page-range>70-73</page-range>
            <pub-id pub-id-type="pmid">30746419</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19490.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Parnes</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bashir</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Jankovic</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Is Benign Hereditary Chorea Really Benign? Brain-Lung-Thyroid Syndrome Caused by <italic>NKX2-1</italic> Mutations.</article-title>
            <source>Mov Disord Clin Pract</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>6</volume>
            <issue>1</issue>
            <fpage>34</fpage>
            <page-range>34-39</page-range>
            <pub-id pub-id-type="pmid">30746413</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19490.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rajan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kaas</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Moukheiber</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Movement Disorders Emergencies.</article-title>
            <source>Semin Neurol</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>39</volume>
            <issue>1</issue>
            <fpage>125</fpage>
            <page-range>125-136</page-range>
            <pub-id pub-id-type="pmid">30743298</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19490.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weber</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Frings</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Rijntjes</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Urbach</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Fischer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Weiller</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Meyer</surname>
                <given-names>PT</given-names>
              </name>
              <name>
                <surname>Klebe</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Chorea-Acanthocytosis Presenting as Autosomal Recessive Epilepsy in a Family With a Novel <italic>VPS13A</italic> Mutation.</article-title>
            <source>Front Neurol</source>
            <year>2018</year>
            <volume>9</volume>
            <fpage>1168</fpage>
            <pub-id pub-id-type="pmid">30687222</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19490.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Klebe</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Timmann</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>[Genetics of movement disorders-rare but important].</article-title>
            <source>Nervenarzt</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>90</volume>
            <issue>2</issue>
            <fpage>197</fpage>
            <page-range>197-210</page-range>
            <pub-id pub-id-type="pmid">30645659</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19490.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bashir</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Jankovic</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Treatment options for chorea.</article-title>
            <source>Expert Rev Neurother</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>51</fpage>
            <page-range>51-63</page-range>
            <pub-id pub-id-type="pmid">29120264</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19490.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yapijakis</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Huntington Disease: Genetics, Prevention, and Therapy Approaches.</article-title>
            <source>Adv Exp Med Biol</source>
            <year>2017</year>
            <volume>987</volume>
            <fpage>55</fpage>
            <page-range>55-65</page-range>
            <pub-id pub-id-type="pmid">28971447</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19490.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van Duijn</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Medical treatment of behavioral manifestations of Huntington disease.</article-title>
            <source>Handb Clin Neurol</source>
            <year>2017</year>
            <volume>144</volume>
            <fpage>129</fpage>
            <page-range>129-139</page-range>
            <pub-id pub-id-type="pmid">28947111</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19490.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Litwin</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Du&#x00161;ek</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Cz&#x00142;onkowska</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Symptomatic treatment of neurologic symptoms in Wilson disease.</article-title>
            <source>Handb Clin Neurol</source>
            <year>2017</year>
            <volume>142</volume>
            <fpage>211</fpage>
            <page-range>211-223</page-range>
            <pub-id pub-id-type="pmid">28433105</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19490.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Carlozzi</surname>
                <given-names>NE</given-names>
              </name>
              <name>
                <surname>Schilling</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kratz</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Paulsen</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Frank</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Stout</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>Understanding patient-reported outcome measures in Huntington disease: at what point is cognitive impairment related to poor measurement reliability?</article-title>
            <source>Qual Life Res</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>27</volume>
            <issue>10</issue>
            <fpage>2541</fpage>
            <page-range>2541-2555</page-range>
            <pub-id pub-id-type="pmid">29909483</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
